About us

eClinicalHealth was founded by a core team of innovators and eClinical pioneers. The team set out with the ambitious plan of not creating ‘yet another system’, but to build something to truly transform clinical trials to be more modern, efficient and patient-centric. Thus, the Clinpal platform was born and has since been received with great enthusiasm in the industry. Today, the platform is already transforming clinical trials and in use in studies ranging from very small (50 patients) to very large (10,000+ patients). Clinpal has been adopted by several organizations, ranging from patient recruitment companies and research institutions to several top 10 pharmaceutical companies.

The Team

Below is the core team responsible for the development of a new kind of a cloud platform targeting site and patient engagement that fits in any existing infrastructure and is suitable for clinical trials across all therapeutic areas and study phases. We are passionate about improving efficiency in clinical trials and we want to integrate and apply best practices across the entire clinical trial process for all stakeholders. Want to join us – check out our careers.

Advisory Board

The Advisory Board is composed of highly experienced individuals that provide an external client and patient view. They also provide industry advice, guidance and direction based on personal knowledge of trends, observations and available data in the industry.

Mark Walton

Mark is a pharmaceutical computer systems quality and compliance (validation) specialist with a thorough knowledge of regulations. He has validated GCP, GLP and GMP systems and has good regulatory authority exposure including face to face interactions with inspectors and regulatory subject matter experts at scientific advisory meetings. He promotes a pragmatic, risk-based, approach to quality and compliance.

Mark has worked in the Life Sciences sector for over 25 years; at Pfizer and as a consultant and at other major Pharmaceuticals. At Pfizer, he was responsible for the quality and compliance status of approx. 45 global computer systems, including systems that supported GxP processes and stored confidential and personal data. The portfolio included systems that were developed and hosted internally and by third parties, Software as a Service (SaaS) deployments and systems developed using agile techniques. Mark also provided quality and compliance expertise on the world’s first virtual clinical trial.

Johann Proeve

Johann studied agro-biology and started his business life in 1980 at Bayer in Clinical Data Management. In 1990 he became Head of Clinical Data Management at Bayer Corp in West Haven, Connecticut, USA before moving on to head up EDC at Bayer Healthcare. In 2000 he became Head of Global Data Management at Bayer Healthcare before being appointed as Global Strategy and Development Advisor in Global Data Sciences and Analytics. As of January 2016, he provides consultancy services in the area of clinical data management, risk based monitoring, the re-use of electronic health records for clinical trials and other related areas.

Miguel Orri

Dr. Miguel Orri, an innovative, highly motivated & results orientated Pharmaceutical Physician with a proven track record of understanding and delivering solutions to complex clinical, technical and operational challenges through cross-functional collaboration.

Dr. Orri qualified in Medicine in 1992 and holds an MD (magna cum laude) from Essen University, Germany. He is a Member of The Royal College of Physicians and a Fellow of The Faculty of Pharmaceutical Medicine. He has extensive experience in the Pharmaceutical Industry at project and management levels across a variety of therapeutic areas and disciplines. More recently he worked in clinical trial excellence and process improvements and conducted the first virtual clinical trial under an IND. After 16 successful years in one of the largest Pharmaceutical companies he has joined eClinicalHealth as a Consulting Partner and Chairman of the Board of Advisors at eClinicalHealth.

At eClinicalHealth, Miguel provides advise on all aspects of clinical development from phase 2 to 4 including clinical development plans, submission dossiers, protocols and clinical study reports with hands on experience in cardiovascular, infectious disease, migraine, chronic back pain, smoking cessation, women’s health and urology.

Dr. Alain M. Cahen, M.D., MBA

Alain has 20 years of Global Healthcare experience in the Pharmaceutical Industry, Diagnostics (Laboratory Medicine) and Clinical Medicine with roles of increasing responsibilities. He has built his expertise as an Executive at Novartis AG, Abbott International and Unilabs SA, in his last function as Member of the Group Executive Management and Managing Director of Switzerland and Italy, leading 900 FTEs and 40 operational sites.

He built a broad local and global expertise in General Management, Marketing & Sales, Operations, Strategy, Drug Development/Portfolio Management and Medical Affairs. He has extensive knowledge of multiple therapeutic areas and Biotechnology. His work experience includes Headquarters and Affiliates (USA, Switzerland, Italy) and he has a strong and successful track record in commercial growth strategies, business development and turn around situations.

Cheryl Fiedler, Pharmaceutical Operations Executive